Gilead Sciences
Search results
Sanjay Singh Chief Executive Officer & Whole-time Director – Gennova Biopharmaceuticals Limited
Namita Thapar is an Indian entrepreneur. She is the Executive Director of Emcure Pharmaceuticals (as of 2022), an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra.
Chief Executive Officer and Managing Director. Satish Mehta is the first-generation entrepreneur and visionary who started Emcure in 1981 with the purpose to provide affordable and high quality healthcare to patients to significantly improve their lives.
Chief Executive Officer at Emcure Pharmaceuticals Limited · Experience: Emcure Pharmaceuticals Limited · Location: Pune · 11 connections on LinkedIn. View Dnyaneshwar Thakur’s profile on...
- Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.
2 days ago · Namita Thapar, Executive Director of Emcure Pharmaceuticals, is a well-known figure in the pharmaceutical industry and one of the wealthiest Shark Tank India judges. She has appeared on the business reality show for three seasons. As per reports, Namita Thapar’s net worth is currently estimated to be Rs 600 crore, which she earned mostly as Executive Director of Emcure Pharmaceuticals. ... In addition to her role at Emcure, Namita also serves as the CEO of Incredible Ventures Ltd, an ...
Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.
Aug 9, 2021 · Satish Mehta, founder and CEO of Emcure Pharmaceuticals, told Sandeep Singh that while he is very satisfied with the primary outcome on safety of the vaccine, he will soon submit the data with CDSCO and apply for next phase trials.
Executive Director, India Business. Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, . Subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business.
